eXmoor Pharma will be a Silver Sponsor at the ESGCT 2026 Annual Congress in Hamburg, 27–30 October. Visit us at booth I-09 to meet our team and discuss your cell and gene therapy programme.
Sep 29, 2026
ESGCT
ESGCT 2026 Annual Congress
Date: 27–30 October 2026
Location: Congress Center Hamburg, Germany
Stand: #I-09
The ESGCT Annual Congress brings together the European gene and cell therapy community across four days of scientific sessions, presentations, posters and networking. The 2026 programme runs from 27 to 30 October in Hamburg.
As a Silver Sponsor, eXmoor Pharma will be exhibiting at booth I-09, with colleagues from our operational and commercial teams available throughout the congress.
Who you’ll meet
- Emma Ewins, Chief Operating Officer
- Alexandre Fouassier, Business Development Director
- Marianna Mavropoulou, Business Development Manager
- Mike Kilcooley, Proposal Manager
If you are working through decisions around process development, analytical strategy, technology transfer or GMP manufacturing, come and speak to Emma, Alex, Marianna or Mike about where your programme is heading and what support you may need next.
Where we can support your programme
Our team works with developers across cell therapy, viral vector and RNA programmes, from early development through to GMP manufacturing and preparation for commercial supply.
Areas we can discuss include:
- Process development and scale-up
- Analytical development and method transfer
- Technology transfer into GMP manufacturing
- GMP clinical manufacturing
- CMC and manufacturing strategy
- Planning for later-phase and commercial supply
Attending ESGCT 2026?
Visit us at booth I-09 during the congress, or contact Emma, Alex, Marianna or Mike in advance to arrange a meeting.
Let’s Accelerate Your Therapy Together
Whether you're in early-stage development or scaling up for commercial production, eXmoor Pharma provides the expertise and flexibility you need. Partner with us to move your therapy forward with confidence.